FDA advisers back Pfizer shot for ages 5-11, paving way for Israel to follow
(Worthy News) – A panel of United States health advisers on Tuesday endorsed kid-size doses of Pfizerâs COVID-19 vaccine, moving the US closer to beginning vaccinations in children ages 5 to 11.
A US Food and Drug Administration advisory panel voted unanimously with one abstention that the vaccineâs benefits in preventing COVID-19 in that age group outweigh any potential risks â including a heart-related side effect thatâs been very rare in teens and young adults who get a much higher dose.
The FDA isnât bound by the panelâs recommendation and is expected to make its own decision within days, though it is widely expected to okay the move. [ Source: Times of Israel (Read More…) ]
FDA Approves Pfizer Vaccine
The FDA committee has approved the Pfizer vaccine under the Emergency Use Authorization for kids aged 5-11, although it conceded it doesn’t know the long-term effects of the vaccination.
A voting member stated, “We’re never gonna learn about how safe the vaccine is until we start giving it.”
đĄ Did you know? One of the best ways you can support Worthy News is by simply leaving a comment and sharing this article.
đ˘ Social media algorithms push content further when thereâs more engagement â so every đ like, đŹ comment, and đ share helps more people discover the truth. đ